Rolltide2020
Nov 19, 3:56 PM
$GLSI The cash balance at the end of Q4 2025 was around
$6.1 million. Almost 1 year later and we are basically at the same level except now we have FDA/EMA trial approval for all HLA types, City of Hope, Royal Mardsden, FDA approval on 1st manufacturing lot, Fast Track approval, and over 1 year of open label data likely still pointing to 70 - 80% reduction. SLS gave us a nice science confirmation this week. Obviously we are going to need more cash (either through ATM or partnership or small raise) somewhere along the way, but for anyone to think money will be the reason we don't make it to finish line seems crazy and anyone who thinks Snehal will do any major dilulitive financing hasn't done their homework.
1 replies